Overview

SUBLIVAC FIX Birch Dose Tolerability/Dose Range Finding

Status:
Completed
Trial end date:
2013-04-01
Target enrollment:
Participant gender:
Summary
The aim of the study is to determine the optimal effective dose of SUBLIVAC FIX Birch based on reduction of upper airways reactivity after 5 months of treatment with different dosages of SUBLIVAC FIX Birch compared to placebo. Furthermore, safety and tolerability will be assessed by the number of related Adverse Events of different dosages of SUBLIVAC FIX Birch compared to placebo.
Phase:
Phase 2
Details
Lead Sponsor:
HAL Allergy